ADHD Treatment-Gap Index: Country Benchmarking for Market Access

A subscription data product that scores each country on the gap between its actual ADHD medication consumption and what its ADHD prevalence would imply, telling pharma market-access teams and health ministries where treatment is absent and whether the barrier is drug supply or diagnosis capacity.